# ClinicalTrials.gov record NCT02817659

> PeptideScanner retained ClinicalTrials.gov record NCT02817659 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon.

- Evidence object: `story:clinicaltrials-gov-nct02817659-glucagon:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-03-30
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02817659-glucagon/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02817659-glucagon-v1.json
- Content SHA-256: `01a00d8c99fba7d6049ffa482d57ee816d2e35ad5eed8ba83041f9c836df3a3c`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02817659 ([`ctg-observation-nct02817659-2026-03-30-4ccb13ddd027`](#source-ctg-observation-nct02817659-2026-03-30-4ccb13ddd027))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02817659 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct02817659-2026-03-30-4ccb13ddd027`](#source-ctg-observation-nct02817659-2026-03-30-4ccb13ddd027))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02817659 at 2026-07-30T16:22:22.328Z. Its registry update date was 2026-03-30, and PeptideScanner's reviewed identity mapping was glucagon. ([`ctg-observation-nct02817659-2026-03-30-4ccb13ddd027`](#source-ctg-observation-nct02817659-2026-03-30-4ccb13ddd027))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02817659-2026-03-30-4ccb13ddd027`](#source-ctg-observation-nct02817659-2026-03-30-4ccb13ddd027))

## Sources

<a id="source-ctg-observation-nct02817659-2026-03-30-4ccb13ddd027"></a>
- **ClinicalTrials.gov record NCT02817659 · retained source version 2026-03-30:4ccb13ddd027d447f6843b208d6e415911da29e4e90207c69b9f419c3f0ac4cf** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02817659) (`ctg-observation-nct02817659-2026-03-30-4ccb13ddd027`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02817659." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02817659-glucagon-v1.json SHA-256: 01a00d8c99fba7d6049ffa482d57ee816d2e35ad5eed8ba83041f9c836df3a3c.